Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications

International Journal of Pharmaceutics

Volumn 410, Issue 1-2, 2011, Pages 145-152

  Rajam, Merlin ^a   Pulavendran, S ^a   Rose, Chellan ^a   Mandal, A B ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

Chitosan nanoparticle; Cytocompatibility; Growth factors; Proinflammatory response; Tissue engineering

Indexed keywords

CHITOSAN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 6; NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; CYTOKINE RESPONSE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FIBROBLAST; FIBROBLAST CULTURE; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTRACELLULAR SIGNALING; MACROPHAGE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUSTAINED DRUG RELEASE; THERMODYNAMICS; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CHITOSAN; CYTOKINES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTORS; FIBROBLASTS; MACROPHAGES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NIH 3T3 CELLS; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE ENGINEERING;

EID: 79955603416     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.02.065     Document Type: Article

References (42)

1. Absolom, D.R., Zingg, W., Neumann, A.W., 1987. Protein adsorption to polymer particles - role of surface-properties. J. Biomed. Mater. Res. 21, 161-171.
2. Allemann, E., Gurny, R., Doelker, E., 1993. Drug-loaded nanoparticles - preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 39, 173-191.
3. Altankov, G., Grinnell, F., Groth, T., 1996. Studiesonthe biocompatibility of materials: fibroblast reorganization of substratum-bound fibronectin on surfaces varying in wettability. J. Biomed. Mater. Res. 30, 385-391.
4. Babensee, J.E., McIntire, L.V., Mikos, A.G., 2000. Growth factor delivery for tissue engineering. Pharm. Res. 17, 497-504.
5. Brannon-Peppas, L., Blanchette, J.O., 2004. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56, 1649-1659.
6. Broadley, K.N., Aquino, A.M., Woodward, S.C., Buckleysturrock, A., Sato, Y., Rifkin, D.B., Davidson, J.M., 1989. Monospecific antibodies implicate basic fibroblast growth-factor in normal wound repair. Lab. Invest. 61, 571-575.
7. Calvo, P., RemunanLopez, C., VilaJato, J.L., Alonso, M.J., 1997. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63, 125-132.
8. Cetin, M., Aktas, Y., Vural, I., Capan, Y., Dogan, L.A., Duman, M., Dalkara, T., 2007. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles. Drug Deliv. 14, 525-529. (Pubitemid 350135855)
9. Chaignaud, B.E., Langer, R., Vacanti, J.P., 1997. The history of tissue engineering using synthetic biodegradable polymer scaffolds and cells. In: Atala, A., Mooney, D.L. (Eds.), Synthetic Biodegradable Polymer Scaffolds. Birkhauser Boston, pp. 1-14.
10. Chen, M., Zamora, P.O., Som, P., Pena, L.A., Osaki, S., 2003. Cell attachment and biocompatibility of polytetrafluoroethylene (PTFE) treated with glow-discharge plasma of mixed ammonia and oxygen. J. Biomater. Sci. Polym. E 14, 917-935.
11. Fernig, D.G., Gallagher, J.T., 1994. Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog. Growth Factor Res. 5, 353-377.
12. Florence, A.T., Hillery, A.M., Hussain, N., Jani, P.U., 1995. Nanoparticles as carriers for oral peptide absorption - studies on particle uptake and fate. J. Control. Release 36, 39-46.
13. Folkman, J., Klagsbrun, M., 1987. Angiogenic factors. Science 235, 442-447. (Pubitemid 17009577)
14. Goodman, S.B., 1996. Does theimmunesystem play a role in loosening and osteolysis of total joint replacements? J. Long Term Eff. Med. Implants 6, 91-101.
15. Haas, T.A., Plow, E.F., 1994. Integrin ligand interactions - a year in review. Curr. Opin. Cell Biol. 65, 656-662.
16. Hallab, N.J., Bundy, K.J., Oconnor, K., Clark, R., Moses, R.L., 1995. Cell adhesion to biomaterials: correlations between surface charge, surface roughness, adsorbed protein, and cell morphology. J. Long Term Eff. Med. Implants 5, 209-231.
17. Illum, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A.N., Davis, S.S., 2001. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 51, 81-96.
18. John, M., Oltmanns, U., Fietze, I., Witt, C., Jung, K., 2002. Increased production of matrix metalloproteinase-2 in alveolar macrophages and regulation by interleukin-10 in patients with acute pulmonary sarcoidosis. Exp. Lung Res. 28, 55-68.
19. Lai, H.L., Abu'Khalil, A., Craig, D.Q.M., 2003. The preparation and characterization of drug-loaded alginate and chitosan sponges. Int. J. Pharm. 251, 175-181.
20. Lamprecht, A., Ubrich, N., Yamamoto, H., Schafer, U., Takeuchi, H., Maincent, P., Kawashima, Y., Lehr, C.M., 2001. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 299, 775-781.
21. Lee, Y.M., Park, Y.J., Lee, S.J., Ku, Y., Han, S.B., Choi, S.M., Klokkevold, P.R., Chung, C.P., 2000. Tissue engineered bone formation using chitosan/tricalcium phosphate sponges. J. Periodontol. 71, 410-417.
22. Lee, J.Y., Nam, S.H., Im, S.Y., Park, Y.J., Lee, Y.M., Seol, Y.J., Chung, C.P., Lee, S.J., 2002. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J. Control. Release 78, 187-197.
23. Logeart-Avramoglou, D., Jozefonvicz, J., 1999. Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: a review. J. Biomed. Mater. Res. 48, 578-590.
24. Moghimi, S.M., Hunter, A.C., Murray, J.C., 2001. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53, 283-318.
25. Musumeci, T., Ventura, C.A., Giannone, I., Ruozi, B., Montenegro, L., Pignatello, R., Puglisi, G., 2006. PLA/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm. 325, 172-179.
26. Na, D.H., Youn, Y.S., Lee, I.B., Park, E.J., Park, C.J., Lee, K.C., 2006. Effect of molecular size of PEGylated recombinant human epidermal growth factor on the biological activity and stability in rat wound tissue. Pharm. Dev. Technol. 11, 513-519.
27. Nimni, M.E., 1997. Polypeptide growth factors: targeted delivery systems. Biomaterials 18, 1201-1225. (Pubitemid 27390300)
28. Pan, Y., Li, Y.J., Zhao, H.Y., Zheng, J.M., Xu, H., Wei, G., Hao, J.S., Cui, F.D., 2002. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm. 249, 139-147.
29. Panyam, J., Labhasetwar, V., 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329-347.
30. Panyam, J., Sahoo, S.K., Prabha, S., Bargar, T., Labhasetwar, V., 2003. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly (d, l-lactide-co-glycolide) nanoparticles. Int. J. Pharm. 262, 1-11.
31. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., Marshak, D.R., 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. (Pubitemid 29282067)
32. Ramge, P., Unger, R.E., Oltrogge, J.B., Zenker, D., Begley, D., Kreuter, J., Von Briesen, H., 2000. Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells. Eur. J. Neurosci. 12, 1931-1940.
33. Ravikumar, M.N.V., 2003. Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharm. Sci. 3, 234-258.
34. Rochev, Y., O'Halloran, D., Gorelova, T., Gilcreest, V., Selezneva, I., Gavrilyuk, B., Gorelov, A., 2004. Rationalising the design of polymeric thermoresponsive biomaterials. J. Mater. Sci. Mater. Med. 15, 513-517.
35. Rudland, P.S., Deasua, L.J., 1979. Action of growth-factors in the cell-cycle. Biochim. Biophys. Acta 560, 91-133.
36. Rusnati, M., Presta, M., 1996. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans - biological implications in neovascularization. Int. J. Clin. Lab. Res. 26, 15-23.
37. Tabata, Y., 2000. The importance of drug delivery systems in tissue engineering. Pharm. Sci. Technol. Today 3, 80-89.
38. Thomas, M., Klibanov, A.M., 2003. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 100, 9138-9143.
39. Thompson, J.A., Anderson, K.D., Dipietro, J.M., Zwiebel, J.A., Zametta, M., Anderson, W.F., Maciag, T., 1988. Site-directed neovessel formation in vivo. Science 241, 1349-1352.
40. Vento, R., Giuliano, M., Lauricella, M., Carabillo, M., Di Liberto, D., Tesoriere, G., 1998. Induction of programmed cell death in human retinoblastoma Y79 cells by C-2-ceramide. Mol. Cell. Biochem. 185, 7-15.
41. Wei, J.H., Yoshinari, M., Takemoto, S., Hattori, M., Kawada, E., Liu, B.L., Oda, Y., 2007. Adhesion of mouse fibroblasts on hexamethyidisiloxane surfaces with wide range of wettability. J. Biomed. Mater. Res. B: Appl. Biomater. 81B, 66-75.
42. Wilkie, A.O.M., Morrisskay, G.M., Jones, E.Y., Heath, J.K., 1995. Functions of fibroblast growth-factors and their receptors. Curr. Biol. 5, 500-507.